Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Caligan Partners LP Stock Portfolio

$428Million– No. of Holdings #13

Caligan Partners LP Performance:
2024 Q2: -1.69%YTD: 14.14%2023: 43.95%

Performance for 2024 Q2 is -1.69%, and YTD is 14.14%, and 2023 is 43.95%.

About Caligan Partners LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Caligan Partners LP reported an equity portfolio of $428 Millions as of 30 Jun, 2024.

The top stock holdings of Caligan Partners LP are LQDA, ALIM, ANIK. The fund has invested 29% of it's portfolio in LIQUIDIA CORPORATION and 21.9% of portfolio in ALIMERA SCIENCES INC.

They significantly reduced their stock positions in Y-MABS THERAPEUTICS INC (YMAB). Caligan Partners LP opened new stock positions in MINERALYS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to BIOCRYST PHARMACEUTICALS INC (BCRX), I MAB (IMAB) and VERONA PHARMA PLC (VRNA).
Caligan Partners LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Caligan Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Caligan Partners LP made a return of -1.69% in the last quarter. In trailing 12 months, it's portfolio return was 51%.

New Buys

Ticker$ Bought
mineralys therapeutics inc8,725,370

New stocks bought by Caligan Partners LP

Additions

Ticker% Inc.
biocryst pharmaceuticals inc506
i mab346
verona pharma plc42.22
exelixis inc38.61
enanta pharmaceuticals inc21.54
evolus inc14.77
agios pharmaceuticals inc6.19

Additions to existing portfolio by Caligan Partners LP

Reductions

Ticker% Reduced
y-mabs therapeutics inc-0.89

Caligan Partners LP reduced stake in above stock

Sold off

None of the stocks were completely sold off by Caligan Partners LP

Sector Distribution

Caligan Partners LP has about 96.6% of it's holdings in Healthcare sector.

Sector%
Healthcare96.6
Others3.4

Market Cap. Distribution

Caligan Partners LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP51.3
MICRO-CAP25.9
MID-CAP19.4
UNALLOCATED3.4

Stocks belong to which Index?

About 60.5% of the stocks held by Caligan Partners LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200060.5
Others39.5
Top 5 Winners (%)%
AGIO
agios pharmaceuticals inc
46.2 %
ALIM
alimera sciences inc
42.6 %
BCRX
biocryst pharmaceuticals inc
10.2 %
Top 5 Winners ($)$
ALIM
alimera sciences inc
27.9 M
AGIO
agios pharmaceuticals inc
7.0 M
BCRX
biocryst pharmaceuticals inc
2.6 M
Top 5 Losers (%)%
OTLK
outlook therapeutics inc
-38.2 %
YMAB
y-mabs therapeutics inc
-25.7 %
ENTA
enanta pharmaceuticals inc
-22.1 %
EOLS
evolus inc
-21.0 %
LQDA
liquidia corporation
-18.6 %
Top 5 Losers ($)$
LQDA
liquidia corporation
-28.5 M
EOLS
evolus inc
-6.3 M
ENTA
enanta pharmaceuticals inc
-3.8 M
YMAB
y-mabs therapeutics inc
-2.5 M
OTLK
outlook therapeutics inc
-2.3 M

Caligan Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Caligan Partners LP

Caligan Partners LP has 13 stocks in it's portfolio. About 96.2% of the portfolio is in top 10 stocks. LQDA proved to be the most loss making stock for the portfolio. ALIM was the most profitable stock for Caligan Partners LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions